14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $96.99 Tuesday, 23rd Apr 2024 BPMC stock ended at $92.29. This is 1.85% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 6.14% from a day low at $89.19 to a day high of $94.67.
90 days $72.25 $100.98
52 weeks $43.89 $100.98

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Dec 03, 2020 $105.79 $107.44 $99.11 $100.35 429 223
Dec 02, 2020 $104.80 $106.81 $104.00 $105.61 373 500
Dec 01, 2020 $109.08 $111.35 $105.15 $105.65 680 623
Nov 30, 2020 $107.61 $109.20 $104.24 $108.08 671 403
Nov 27, 2020 $105.21 $108.12 $105.21 $107.26 163 858
Nov 25, 2020 $103.59 $106.02 $103.50 $105.32 700 683
Nov 24, 2020 $99.07 $103.44 $98.89 $103.34 794 142
Nov 23, 2020 $97.55 $100.16 $96.70 $98.76 545 814
Nov 20, 2020 $95.73 $98.77 $94.28 $97.65 606 937
Nov 19, 2020 $94.93 $96.72 $94.42 $96.71 410 159
Nov 18, 2020 $98.73 $100.01 $94.63 $95.44 446 939
Nov 17, 2020 $97.71 $99.90 $96.86 $99.00 411 414
Nov 16, 2020 $100.92 $101.93 $97.16 $98.50 321 507
Nov 13, 2020 $101.53 $102.57 $100.23 $100.72 192 006
Nov 12, 2020 $101.62 $103.75 $99.05 $100.49 267 764
Nov 11, 2020 $101.42 $102.01 $98.18 $101.25 296 645
Nov 10, 2020 $100.14 $101.52 $96.51 $101.22 329 384
Nov 09, 2020 $101.78 $103.90 $97.90 $99.14 350 296
Nov 06, 2020 $101.65 $101.93 $96.32 $98.57 344 092
Nov 05, 2020 $101.19 $104.50 $99.69 $101.53 427 121
Nov 04, 2020 $97.96 $104.76 $97.96 $101.24 521 918
Nov 03, 2020 $99.69 $101.80 $94.72 $96.53 720 289
Nov 02, 2020 $101.15 $103.42 $93.13 $98.47 664 656
Oct 30, 2020 $106.08 $106.08 $100.98 $102.28 624 254
Oct 29, 2020 $106.30 $108.51 $102.09 $106.84 550 518
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT